Walmart is rolling out its own personalized blood tests to test for the most common types of cancer and to monitor the health of customers.
The new tests are being rolled out in stores nationwide on Thursday, including in stores that previously had to rely on a different test that may have been contaminated by the coronavirus.
The new tests have been created specifically for Walmart employees, including the CEO of the retailer, CFO of Walmart Sam Dickson, and COO of Walmart Jeff Buhl.
They are available to people who have the CHRNA test, the most commonly tested test for colorectal cancer.
That test is also called a non-invasive, non-biologic test.
The test tests for the CHRN, a protein found in cells that are the target of the cancer.
The new test is being rolled-out by Walmart in two types of stores: Walmart Supercenters and Walmart Neighborhoods.
The tests are meant to be used by employees who are already testing for a specific disease, but the tests will also be available to Walmart customers who are visiting Walmart stores or who are shopping at a store where the tests are available.
“We know that our customers are important and we want them to know that we’re here to help them and provide them with the best health care possible,” Walmart said in a statement.
Dickson told reporters on Wednesday that the tests would not replace the tests that are currently available in Walmart stores.
“You know, we’re not going to replace the CHTN test.
It’s a testing tool, it’s a test, it works, it is our best testing tool,” he said.
He added that the new tests would also provide a way for Walmart to monitor customers, “to see how they’re doing.”
Walmart stores have been able to use the CHN test for more than a decade, but some stores, including Walmart, have had to replace it with a noninvasive test.
A study released last month found that about 40 percent of people who tested positive for the coronivirus were taking the noninvasively developed test.